Congressional spending plan: What’s in it for healthcare, and what isn’t
Chief Healthcare Executive December 21, 2024
STAT+: With RFK Jr. looming as health secretary, pharma execs try to project stability
STAT November 19, 2024
Pharma executives at an investor conference minimized the potential impact of RFK Jr. at HHS
LONDON — Robert F. Kennedy Jr. has been a vocal critic of the pharma industry. He’s said it’s corrupted U.S. health agencies and has attacked, often with false arguments, products from vaccines to obesity medications.
So when President-elect Trump, who...
Today's Sponsors
Today's Sponsor